Patent application number | Description | Published |
20090280415 | TRANSPARENT SUBSTRATE FOR MASK BLANK AND MASK BLANK - In a transparent substrate for a mask blank, which is required to have a predetermined optical characteristic, a substrate mark is formed by cutting off a predetermined corner portion into an oblique section. The shape of the mark is determined in accordance with the optical characteristic of he substrate. | 11-12-2009 |
20100035164 | MASK BLANK SUBSTRATE, MASK BLANK, EXPOSURE MASK, MASK BLANK SUBSTRATE MANUFACTURING METHOD, AND SEMICONDUCTOR MANUFACTURING METHOD - In a mask blank substrate to be chucked by a mask stage of an exposure system, the flatness of a rectangular flatness measurement area excluding an area of 2 mm inward from an outer peripheral end surface on a main surface of the mask blank substrate on its side to be chucked by the mask stage is 0.6 μm or less, and at least three of four corner portions of the flatness measurement area each have a shape that rises toward the outer peripheral side. | 02-11-2010 |
20100248092 | MASK BLANK SUBSTRATE, MASK BLANK, EXPOSURE MASK, MASK BLANK SUBSTRATE MANUFACTURING METHOD, AND SEMICONDUCTOR MANUFACTURING METHOD - In a mask blank substrate to be chucked by a mask stage of an exposure system, the flatness of a rectangular flatness measurement area excluding an area of 2 mm inward from an outer peripheral end surface on a main surface of the mask blank substrate on its side to be chucked by the mask stage is 0.6 μm or less, and at least three of four corner portions of the flatness measurement area each have a shape that rises toward the outer peripheral side. | 09-30-2010 |
Patent application number | Description | Published |
20090032839 | Semiconductor Device and Its Driving Method - A semiconductor device having a thyristor SCR with reduced turn-off time. A third semiconductor region of the second conductivity type (anode AN) and a fourth semiconductor region of the first conductivity type (anode gate AG) are formed in the top layer of a first semiconductor region; fifth semiconductor region of the first conductivity type (cathode CA) and sixth semiconductor region of the second conductivity type (cathode gate CG) are formed in the top layer of a second semiconductor region; a gate insulating film and gate electrode MG are formed on the second semiconductor region. When the thyristor is turned off from the on state, a higher potential than that on the anode is applied to the anode gate, and a diode made up of the anode and the anode gate inside the thyristor is made to conduct so as to control the potential of the anode during driving. | 02-05-2009 |
20090243016 | SEMICONDUCTOR DEVICE - An apparatus is provided. The apparatus generally comprises a photoreceptive region and a circuit region formed in a substrate. A multilayer wiring region is then formed on the substrate over at least a portion of the circuit region. The multilayer wiring region includes a wiring layer and a light-blocking layer. The wiring layer is coupled to the circuit region, and the light-blocking wall has a metal layer that is arranged along at least a portion of the perimeter of the photoreceptive region and that is formed in the same process step as the wiring layer. | 10-01-2009 |
20100032713 | LATERAL INSULATED GATE BIPOLAR TRANSISTOR - Current density in an insulated gate bipolar transistor (L-IGBT) may be increased by adding a second gate, and the corresponding MOS transistors, to the source area, which increases the base current compared to a L-IGBT with a single MOS gate. The current density may be further increased by extending the base of the bipolar transistor in the L-IGBT vertically to the bottom surface of the silicon on insulator (SOI) film in which the L-IGBT is fabricated. Adding a buffer diffused region around the sinks in the source improves the base current spatial uniformity, which improves the safe operating area (SOA) of the L-IGBT. A L-IGBT of either polarity may be formed with the inventive configurations. A method of forming the inventive L-IGBT is also disclosed. | 02-11-2010 |
20130032863 | INTEGRATED GATE CONTROLLED HIGH VOLTAGE DIVIDER - An integrated circuit containing a gate controlled voltage divider having an upper resistor on field oxide in series with a transistor switch in series with a lower resistor. A resistor drift layer is disposed under the upper resistor, and the transistor switch includes a switch drift layer adjacent to the resistor drift layer, separated by a region which prevents breakdown between the drift layers. The switch drift layer provides an extended drain or collector for the transistor switch. A sense terminal of the voltage divider is coupled to a source or emitter node of the transistor and to the lower resistor. An input terminal is coupled to the upper resistor and the resistor drift layer. A process of forming the integrated circuit containing the gate controlled voltage divider. | 02-07-2013 |
20130032922 | INTEGRATED HIGH VOLTAGE DIVIDER - An integrated circuit containing a voltage divider having an upper resistor of unsilicided gate material over field oxide around a central opening and a drift layer under the upper resistor, an input terminal coupled to an input node of the upper resistor adjacent to the central opening in the field oxide and coupled to the drift layer through the central opening, a sense terminal coupled to a sense node on the upper resistor opposite from the input node, a lower resistor with a sense node coupled to the sense terminal and a reference node, and a reference terminal coupled to the reference node. A process of forming the integrated circuit containing the voltage divider. | 02-07-2013 |
Patent application number | Description | Published |
20090176284 | PROCESS FOR PREPARING CONCENTRATED POLYUNSATURATED FATTY ACID OIL - The present invention provides a process for concentrated PUFA oil, characterized in that alcoholysis reaction using lipase is carried out in the presence of a small amount of water and at least one compound as an additive selected from magnesium oxide, magnesium hydroxide, calcium oxide and calcium hydroxide, and then separation is conducted to obtain a glyceride fraction. | 07-09-2009 |
20100190220 | METHOD FOR PRODUCING EPA-ENRICHED OIL AND DHA-ENRICHED OIL - Alcoholysis of oils and fats containing EPA and DHA is performed by a lipase having substrate specificity for fatty acids having 18 carbons or less and in the presence of a reaction additive such as magnesium oxide; then the glyceride fraction is separated; alcoholysis of the glyceride fraction is performed by a lipase having substrate specificity for fatty acids having 20 carbons or less and in the presence of a reaction additive such as magnesium oxide; and EPA-enriched oil and DHA-enriched oil are simultaneously obtained. | 07-29-2010 |
20120022153 | TRICYCLIC CONDENSED HETEROCYCLIC COMPOUND, PROCESS OF PRODUCING SAME, AND USE THEREOF - A novel compound derived from the culture product of an actinomycete and having an antitumor activity is provided. Provided is a compound represented by any one of formulas (I), (II) and (III) | 01-26-2012 |
20130108247 | STORAGE SYSTEM | 05-02-2013 |
20130109134 | METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE | 05-02-2013 |
20130185637 | Information Processing Apparatus, Information Processing Method and Program - An information processing apparatus capable of simultaneously executing a reproduction function of content data and a communication function with an external apparatus includes a reproduction section configured to execute the reproduction function, a communication control section configured to execute the communication function using a communication section, an operation input allocation section configured to allocate an operation input from a first operation section to the reproduction function or the communication function, an operation input acquisition section configured to acquire an operation input from a second operation section, and a display control section configured to cause a display section to display information relating to the reproduction function or information relating to the communication function. | 07-18-2013 |
20140275251 | COMPOSITION FOR EXTERNAL USE ON SKIN FOR INFLAMMATORY DISEASES - [Problem] Provision of a composition for external use on skin that is safe to use and has an anti-inflammatory and anti-allergic actions. [Solution] A composition for external use on skin in the treatment of inflammatory disease which comprises dihomo-γ-linolenic acid (DGLA) as an active ingredient. The DGLA is preferably contained as a glyceride, a phospholipid, or an alkyl ester. The composition for external use contains DGLA in an amount of 0.1-50 wt %. | 09-18-2014 |
20150046573 | INFORMATION PROCESSING SYSTEM, INFORMATION PROCESSING APPARATUS, AND SERVER - In a media server, a registration processing block registers a client apparatus connectable to the media server and an information provision block provides information related with the registered client apparatus to an information processing apparatus. In the information processing apparatus, when an information acquisition block acquires information related with two or more client apparatuses, then a display processing block generates display data for displaying type identification information and device identification information for each client apparatus. The type identification information is a name of the client apparatus and the device identification information is a MAC address. | 02-12-2015 |
20150058896 | INFORMATION PROCESSING SYSTEM AND MEDIA SERVER - In a media server, a storage unit | 02-26-2015 |
20150200520 | METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE, SEMICONDUCTOR DEVICE AND SYSTEM FOR MANUFACTURING SEMICONDUCTOR DEVICE - A method for manufacturing a semiconductor device includes forming a lower light confinement layer on a substrate, a light absorption layer on the lower light confinement layer, and an upper light confinement layer on the light absorption layer; and removing parts of these layers to form an optical modulator, forming a laser section having a diffraction grating in a portion of the substrate where the optical modulator is not present, forming a diffusion constraining layer, which constrains diffusion of a dopant, on the upper light confinement layer, and forming a contact layer on the laser section and the diffusion constraining layer. The same dopant is present in the contact layer and the upper light confinement layer. | 07-16-2015 |
20150244152 | METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE - A method of manufacturing a semiconductor device, includes forming a laser section on a portion of a substrate, the laser section including an active layer, an upper semiconductor layer on the active layer, and a mask on the upper semiconductor layer; forming a compound semiconductor layer of an indium-containing material in contact with a side of the laser section, the compound semiconductor layer having a projection immediately adjacent the laser section; and wet etching and removing the projection with an etchant containing hydrobromic acid and acetic acid, planarizing the compound semiconductor layer, and producing a (111)A surface in the upper semiconductor layer, under the mask. | 08-27-2015 |
20160051504 | COMPOSITION FOR EXTERNAL USE ON SKIN FOR INFLAMMATORY DISEASES - [Problem] To provide a composition for external skin use that has anti-inflammatory and antiallergic activity, and is very safe. [Solution] A composition for external skin use for inflammatory diseases contains dihomo-gamma-linolenic acid (DGLA) as the active ingredient thereof. It is preferable for the DGLA to be present as a glyceride, a phospholipid, or an alkyl ester. The amount of DGLA contained in the composition for external use is 0.1-50 wt %. | 02-25-2016 |
Patent application number | Description | Published |
20140071325 | IMAGING APPARATUS AND IMAGING PROCESSING METHOD CAPABLE OF CHECKING COMPOSITION IN ADVANCE, AND STORAGE MEDIUM THEREFOR | 03-13-2014 |
20140079290 | IMAGE PROCESSING DEVICE FOR PERFORMING IMAGE PROCESSING ON MOVING IMAGE - An image processing device executes: a determination process of determining similarity of a motion of a subject in each of a plurality of pieces of moving image data stored in the storing unit; a selection process of selecting a specific piece of moving image data from among the pieces of moving image data on the basis of the similarity determined by the determination step; and an output process of outputting information of a selection result by the selection step. | 03-20-2014 |
20140362246 | PHOTOGRAPHING CONTROLLER FOR CONTROLLING PHOTOGRAPHING EXECUTED BY A PLURALITY OF CAMERAS - A master camera sets temporary conditions at the time of executing photographing by a plurality of cameras, determines whether photographing by the plurality of cameras can be executed under the temporary conditions, sets actual conditions at the time of executing photographing by the plurality of cameras in accordance with this determination result, and executes control such that photographing by the plurality of cameras is executed under the actual conditions. | 12-11-2014 |
20150029350 | IMAGING APPARATUS CAPABLE OF WIRELESS COMMUNICATION - An imaging apparatus of the present invention, which is capable of wireless communication, images a peripheral imaging apparatus from among a plurality of peripheral imaging apparatuses around the imaging apparatus; detects predetermined information by which identification information identifying the peripheral imaging apparatus is identifiable from within the imaging frames; identifies the identification information by analyzing the detected predetermined information; selects a peripheral imaging apparatus to be a target for predetermined processing from among the plurality of peripheral imaging apparatus by using the identified identification information; and performs the predetermined processing with the selected peripheral imaging apparatus via the wireless communication. | 01-29-2015 |
20150063775 | MOVING IMAGE GENERATION SYSTEM THAT GENERATES ONE MOVING IMAGE BY COUPLING A PLURALITY OF MOVING IMAGES - A moving image generation system includes: acquiring a plurality of moving images acquired by performing continuous photography by a plurality of image capture units that is disposed so as to differentiate their photographing areas; detecting, by way of image recognition, from within each moving image acquired, a subject arbitrarily designated; according to each timing in the continuous photography, selects a moving image including a subject-included area in which the subject detected is included at a predetermined position or in a predetermined size, and clips an image within the subject-included area; and couples the plurality of images that is clipped in the order of photographing time to generate a single moving image. | 03-05-2015 |
20150382135 | WIRELESS COMMUNICATION APPARATUS, WIRELESS COMMUNICATION METHOD AND COMPUTER READABLE RECORDING MEDIUM RECORDING PROGRAM THEREON - An embodiment of the present invention provides a wireless communication apparatus which can automatically switch to an operation mode corresponding to a communication target. The wireless communication apparatus detects a communication target near to the wireless communication apparatus. It determines whether or not the detected communication target is capable of P2P communication with the wireless communication apparatus. In the case of determining that the communication target is capable of P2P communication, the wireless communication apparatus determines that the communication target is a mobile terminal and switches the operation mode to a P2P mode to establish P2P communication with the mobile terminal. In the case of determining that the communication target is not capable of P2P communication, the wireless communication apparatus determines that the communication target is a contactless IC card and switches the operation mode to a reader/writer mode to read/write information from/to the contactless IC card. | 12-31-2015 |
20160071542 | INFORMATION OUTPUT DEVICE AND COMPUTER READABLE MEDIUM - An information output device includes an output unit, a recognition unit and a control unit. The output unit outputs a content. The recognition unit recognizes a user. The control unit (i) determines whether the content currently being output by the output unit is suitable for the recognized user, thereby producing a determination result and (ii) changes, on the basis of the determination result, the current output content to a content having the same substance as the current output content but a different playback time from the current output content. | 03-10-2016 |
Patent application number | Description | Published |
20090188494 | DRUG EJECTION APPARATUS, ESTIMATION OF EJECTION PERFORMANCE THEREOF, AND METHOD OF DRUG EJECTION - A drug ejection apparatus comprises a drug ejection assembly having an ejection port and an element for generating energy for ejecting a drug through the ejection port, a drug container connected with the drug ejection assembly for holding the drug, a pressure sensor unit for sensing a pressure change in the inside of the drug container in correspondence with ejection of the drug through the drug ejection assembly, and a drive control unit for deciding driving conditions of the element for ejecting a prescribed amount of the drug by reference to an output level of the pressure sensor unit on driving the element under prescribed conditions. | 07-30-2009 |
20090260443 | TEST METHOD OF OPERATIONS OF ULTRASONOGRAPH AND ULTRASOUND PROBE - Provided is an ultrasonograph and the like capable of easily specifying defective parts of an ultrasound probe and appropriately treating the defective parts. A test method of an operation of an ultrasound probe that transmits and receives a signal of ultrasound for creating a diagnostic image in an ultrasonograph includes: bringing a test material into contact with the ultrasound probe and transmitting a first ultrasound from the ultrasound probe to the test material by a first transmitting circuit connected to the ultrasound probe; receiving, by a first receiving circuit connected to the ultrasound probe, a received signal of a reflected wave of the first ultrasound received by the test material and receiving, by a second receiving circuit connected to the test material, a received signal of the first ultrasound received by the test material; and comparing the received signals with each normal received signal stored in a memory and determining whether the operation of the ultrasound probe is normal or defective based on the comparison result. | 10-22-2009 |
20090283094 | MEDICINE EJECTION DEVICE - In a medicine ejection device for administering a medicine to the throat, bronchi or lungs, the air flow path to which the medicine has stuck is to be kept in clean state in a simple configuration. The medicine ejection device which ejects a medicine to be inhaled by a user via a suction port, including a flow path member linked to the suction port and capable of forming an air flow path in which the medicine is guided by the inhalation by the user to the suction port, and an internal wall face constituting member which is intended for formation of the internal wall of the air flow path and allows detachable fitting in the flow path member. | 11-19-2009 |
20100275916 | MEDICINE EJECTION APPARATUS AND CONTROL METHOD THEREOF - A medicine ejection apparatus which ejects a medicine for medicating a user comprises; a medicine ejecting unit which has an element that generates energy for ejecting the medicine, a drive control unit which controls a drive start and a drive stop of the element, and an ejection amount determining unit which determines a total amount of a medicine that is ejected from the medicine ejecting unit after the element performs a drive stop, the drive control unit enabling the element to perform driving so as to eject an amount of medicine calculated from difference between the set ejection amount and the total amount of medicine when the total amount of medicine determined by the ejection amount determining unit does not reach the set ejection amount. | 11-04-2010 |
20100282254 | DRUG EJECTING APPARATUS AND CONTROL METHOD THEREOF - A drug ejecting apparatus comprises a drug ejection apparatus which has an ejection port and an element which generates energy for ejecting a drug from the ejection port; a drug containing unit which is connected to the drug ejection apparatus, and contains the drug; a movable wall which is attached to an end of the drug containing unit, and is displaced by difference between pressures from the inside and outside of the drug containing unit; and a control unit which displaces the movable wall, wherein the drug ejection apparatus is filled with the drug, and inside pressure of the drug containing unit is made into a negative pressure state in advance of ejecting of the drug, by displacing the movable wall by the control unit. | 11-11-2010 |
20120133469 | TRANSFORMER - A transformer that improves the DC superposition characteristic without incurring eddy-current losses. In the transformer, a part of a plate-like core opposing a top face of a flange of a drum core is formed with a first opposing portion opposing none of input and output terminals and a second opposing portion opposing the input and output terminals. A first gap is formed between the top face and the first opposing portion by a spacer. A second gap greater than the first gap is formed by a recess of the plate-like core provided so as to correspond to the second opposing portion. This allows magnetic fluxes to pass between the top face and the first opposing portion where the gap is formed and inhibits them from passing between the plate-like core and the input and output terminals where the second gap greater than the first gap is formed. | 05-31-2012 |
Patent application number | Description | Published |
20090203797 | Antimycotic Patch - A nail and/or skin patch for preventing or treating mycoses is provided that is able to maintain a drug concentration in the nails and/or skin horny layer at a high concentration for a long period of time without adding a dissolving agent that prevents precipitation of drug crystals or permeation enhancer that promotes penetration of drug into the nails and/or skin, retains superior adhesion even when adhered for a long period of time and has causes little skin irritation. | 08-13-2009 |
20120234977 | COUPLING STRUCTURE FOR AIRFRAME COMPONENTS - Provided is a coupling structure for airframe components that is capable of ensuring sufficient lightning protection capability. A conductive pattern part | 09-20-2012 |
20140096991 | COUPLING STRUCTURE FOR AIRFRAME COMPONENTS - Provided is a coupling structure for airframe components that is capable of ensuring sufficient lightning protection capability. A conductive pattern part | 04-10-2014 |
20140171886 | Patch for Treatment of Eyelid Disease Containing Clobetasol - A patch for treatment of eyelid diseases that is provided with a support, a pressure-sensitive adhesive layer, and a release layer in this order, wherein (a) the pressure-sensitive adhesive layer includes the following (a-1) to (a-4): (a-1) a styrene-isoprene-styrene block copolymer, a tackifier resin, and a softening agent are contained; (a-2) a ratio (mass ratio) of the styrene-isoprene-styrene block copolymer and the tackifier resin is 1:2 to 1:4; (a-3) a content of the softening agent is 40% to 60% by mass; and (a-4) further 0.005% to 5% by mass of clobetasol or acid ester thereof is contained; and (b) the support has elastic modulus with a Young's modulus of 0.01 to 0.5 GPa: and a method for producing the patch for treatment of eyelid diseases including: forming a pressure-sensitive adhesive layer on a upper surface of a release layer. | 06-19-2014 |
20150209301 | PATCH FOR ANTI-DERMATOPHYTOSIS - A patch for nails or skin for prevention or treatment of dermatophytosis, containing a layer including a pressure sensitive adhesive layer and a compound represented by the formula: | 07-30-2015 |
20150218877 | INSULATED GLAZING AND METHOD OF PRODUCING INSULATED GLAZING - Insulated glazing includes a first glass substrate including a first surface, a second glass substrate including a second surface facing the first surface across a gap, and a sealing member hermetically sealing the gap. The sealing member includes a metal member of a frame shape including third and fourth surfaces, and first and second joining layers. The first joining layer is placed in a frame shape on the first surface of the first glass substrate. The second joining layer is placed in a frame shape on the second surface of the second glass substrate, and is in a position offset from the position of the first joining layer when viewed in a thickness direction of the insulated glazing. The first joining layer is bonded to part of the third surface of the metal member. The second joining layer is bonded to part of the fourth surface of the metal member. | 08-06-2015 |
20150320606 | Facial Patch - Provided is a facial patch including a support, a pressure-sensitive adhesive layer, and a release layer in this order, in which (a) the pressure-sensitive adhesive layer satisfies the following conditions (a-1) to (a-3): (a-1) the pressure-sensitive adhesive layer contains a styrene-isoprene-styrene block copolymer, a tackifier resin, and a softening agent; (a-2) the ratio (mass ratio) of the styrene-isoprene-styrene block copolymer and the tackifier resin is 1:2 to 1:4; and (a-3) the content of the softening agent is 40% to 60% by mass; and (b) the support has elastic moduli with a Young's modulus of 0.01 GPa to 0.5 GPa, and also provided is a method for producing the facial patch, the method including a step of forming a pressure-sensitive adhesive layer on the upper surface of the release layer. | 11-12-2015 |
Patent application number | Description | Published |
20090155343 | Tamsulosin-Containing Transdermal Patch - A tamsulosin-containing transdermal patch. A transdermal patch comprising a backing-layer and an adhesive layer on the backing-layer, characterized in that the adhesive layer contains an acrylic adhesive, further contains tamsulosin as an active ingredient in an amount of 0.1 to 20% by mass of the total mass of the adhesive layer and, if desired, a polyoxyethylene alkyl ether which is an additive playing a role in increasing solubility and a propylene glycol fatty acid ester which is an additive playing a role in promoting percutaneous absorption is provided. Further, a transdermal patch comprising a backing-layer and an adhesive layer on the backing-layer, characterized in that the adhesive layer contains a synthetic rubber adhesive, further contains tamsulosin as an active ingredient in an amount of 0.1 to 20% by mass of the total mass of the adhesive layer and a propylene glycol fatty acid ester which is an additive playing a role in promoting percutaneous absorption is provided. | 06-18-2009 |
20090220580 | Percutaneous Absorption Formulation - The present invention provides a percutaneous absorption formulation including a patch having an adhesive layer disposed on a substrate and the adhesive layer contains ketotifen fumarate and tris(hydroxymethyl)aminomethane, and the patch is packaged in a hygroscopic packaging material. In the percutaneous absorption formulation, tris(hydroxymethyl)aminomethane particularly selected from various basic substances is incorporated, and by packaging the patch in a hygroscopic packaging material, the percutaneous absorptivity and content stability of a drug can be simultaneously improved and the yellowing of the drug can be suppressed. These effects can be further improved by the incorporation of propyl gallate, the use of an adhesive layer including an SIS-based adhesive base and a rosin ester-based adhesion imparting resin, and/or the removal of oxygen from the atmosphere in the inside of the packaging material. | 09-03-2009 |
Patent application number | Description | Published |
20090031437 | Method of constructing nucleus-implanted egg, parthenogenetic embryo and parthenogenetic mammal - The present invention is to provide a method for constructing a nucleus-implanted egg, a parthenogenetic embryo and for producing a parthenogenetic mammal each having 2 haploid genome sets originating in mammarian ova, and provides methods of constructing a nucleus-implanted egg having a haploid genome set derived from ng ovum and a haploid genome set from fg ovum, a parthenogenetic embryo and a parthenogenetic mammal, which includes the steps of (1) introducing a primitive ovarian follicle egg (ng ovum) into a nucleus-deleted egg in a germinal vesicle stage (GV stage egg) and then developing them to MII phase (second meiosis metaphase) by in vitro maturing and culturing to prepare a first nucleus-implanted egg, and (2) extracting MII phase chromosome from said first nucleus-implanted egg and introducing it into other MII phase egg (fg ovum) to prepare a second nucleus-implanted egg, wherein ovum from which an imprinted gene that undergoes gene modification posteriori during the generation of sperm is deleted is used as the ng ovum or fg ovum. | 01-29-2009 |
20100122364 | METHOD OF CONSTRUCTING NUCLEUS-IMPLANTED EGG, PARTHENOGENETIC EMBRYO AND PARTHENOGENETIC MAMMAL - Disclosed is a method for constructing a nucleus-implanted egg, a parthenogenetic embryo and for producing a parthenogenetic mammal each having 2 haploid genome sets originating in mammalian ova, and provides methods of constructing a nucleus-implanted egg having a haploid genome set derived from primitive ovarian follicle egg (ng ovum) and a haploid genome set from MII phase (second meiosis metaphase) egg (fg ovum), a parthenogenetic embryo and a parthenogenetic mammal, including steps (1) introducing ng ovum into a nucleus-deleted deleted germinal vesicle stage (GV) egg, developing the obtained egg to MII phase by in vitro maturing and culturing to prepare a first nucleus-implanted egg, and (2) extracting MII phase chromosome from the first nucleus-implanted egg and introducing it into other fg ovum to prepare a second nucleus-implanted egg, wherein a ng or fg ovum from which an imprinted gene undergoing epigenetic modification during sperm generation is used. | 05-13-2010 |
Patent application number | Description | Published |
20090218634 | SEMICONDUCTOR DEVICE AND MANUFACTURING METHOD OF THE SAME - Provided is a highly reliable semiconductor device equipped with a plurality of semiconductor elements having desired properties, respectively; and a manufacturing method facilitating the manufacture of the semiconductor device. The semiconductor device is manufactured by forming a gate-electrode metal film having a thickness of from 3 to 30 nm over the entire upper surface of a gate insulating film; forming an n-side cap layer having a thickness of 10 nm or less over the entire upper surface of a portion of the gate-electrode metal film belonging to an nFET region by using a material different from that of the gate-electrode metal film; and carrying out heat treatment over the n-side cap layer to diffuse the material of the n-side cap layer into the gate-electrode metal film immediately below the n-side cap layer and react them to form an n-side gate-electrode metal film in a nFET region. A poly-Si layer is then deposited, followed by gate electrode processing. | 09-03-2009 |
20100279496 | MANUFACTURING METHOD OF SEMICONDUCTOR DEVICE - To improve productivity and performance of a CMISFET including a high-dielectric-constant gate insulating film and a metal gate electrode. An Hf-containing insulating film for a gate insulating film is formed over the main surface of a semiconductor substrate. A metal nitride film is formed on the insulating film. The metal nitride film in an nMIS formation region where an n-channel MISFET is to be formed is selectively removed by wet etching using a photoresist pattern on the metal nitride films a mask. Then, a threshold adjustment film containing a rare-earth element is formed. The Hf-containing insulating film in the nMIS formation region reacts with the threshold adjustment film by heat treatment. The Hf-containing insulating film in a pMIS formation region where a p-channel MISFET is to be formed does not react with the threshold adjustment film because of the existence of the metal nitride film. Then, after removing the unreacted threshold adjustment film and the metal nitride film, metal gate electrodes are formed in the nMIS formation region and the pMIS formation region. | 11-04-2010 |
20110057265 | SEMICONDUCTOR DEVICE AND MANUFACTURING METHOD OF THE SAME - Provided is a highly reliable semiconductor device equipped with a plurality of semiconductor elements having desired properties, respectively; and a manufacturing method facilitating the manufacture of the semiconductor device. The semiconductor device is manufactured by forming a gate-electrode metal film having a thickness of from 3 to 30 nm over the entire upper surface of a gate insulating film; forming an n-side cap layer having a thickness of 10 nm or less over the entire upper surface of a portion of the gate-electrode metal film belonging to an nFET region by using a material different from that of the gate-electrode metal film; and carrying out heat treatment over the n-side cap layer to diffuse the material of the n-side cap layer into the gate-electrode metal film immediately below the n-side cap layer and react them to form an n-side gate-electrode metal film in a nFET region. A poly-Si layer is then deposited, followed by gate electrode processing. | 03-10-2011 |
Patent application number | Description | Published |
20080285336 | SEMICONDUCTOR DEVICE - To improve the reliability of the phase change element, unwanted current should not be flown into the element. Therefore, an object of the present invention is to provide a memory cell that stores information depending on a change in its state caused by applied heat, as well as an input/output circuit, and to turn off the word line until the power supply circuit is activated. According to the present invention, unwanted current flow to the element can be prevented and thereby data destruction can be prevented. | 11-20-2008 |
20140154790 | BIOMOLECULE INFORMATION ANALYSIS DEVICE - Provided is a device that, on the basis of a measurement result of a current that has a low value and a wide distribution, identifies the composition of biological molecules passing through a nanoparticle path. This biomolecule information analysis device obtains a current value by applying an electrical field to biomolecules passing through a gap between a first electrode and a second electrode, and identifies the structure of the biomolecules by integrating the current value and making a comparison with a reference value (see FIG. | 06-05-2014 |
20150362458 | BIOMOLECULE MEASURING DEVICE - Provided is a biomolecule measuring device capable of effectively reducing measurement noise occurring when measuring a biomolecule sample using a semiconductor sensor. This biomolecule measuring device generates a trigger to react a sample with a reagent after starting to send the reagent onto the semiconductor sensor that detects ion concentration (see FIG. | 12-17-2015 |
Patent application number | Description | Published |
20090020049 | WASTE DISPOSING APPARATUS - The present invention relates to a waste disposing apparatus that, rather than using incineration, uses a system wherein heat is applied to a magnetic field generated by compounded granulated ores to promote the occurrence and activation of plasma, resulting in the maintenance of a high temperature in the disposing apparatus that is sufficient to subject to a high heat consumption disposing the waste placed therein. The waste disposing apparatus of the present invention comprises a main body of a rectangular shaped waste disposing apparatus, a waste input port and a shutter located on top thereof, an opening located near the bottom of a side face of the main body for inserting a heating material there into, and a plurality of pipe-inserting holes located in peripheral side faces thereof; wherein a plurality of pipes are inserted and fitted to all of the pipe-inserting holes in the direction of a hollow inside of the main body; and compounded granulated ores generating a magnetic field are placed on the base of the plurality of pipes located on the outside of side walls of the main body and on the bottom face of the main body. | 01-22-2009 |
20130128622 | POWER CONVERTING APPARATUS - A power converting apparatus makes reduction of power loss possible and operates in a two-phase mode. A power converting apparatus of the inventive concept includes I-shaped block cores, each being made of a magnetic material; and E-shaped cores, each being produced by combining two L-shaped magnetic materials to each of the I-shaped cores. In each of the E-shaped cores, the block core is defined as a central leg, the other two legs are defined as a first outside leg and a second outside leg, respectively, and a closed magnetic path is configured by two E-shaped cores combined such that one of respective central legs in the two E-shaped cores, one of respective first outside legs therein, and one of respective second outside legs therein are caused to face the other of the central legs, the other of the first outside legs, and the other of the second outside legs. | 05-23-2013 |
Patent application number | Description | Published |
20130234955 | COORDINATE INPUT APPARATUS - A coordinate input apparatus includes a light projecting unit configured to project light parallelly to an effective coordinate input region, a reflection unit configured to retroreflect the light projected by the light projecting unit, and a light receiving unit configured to receive light from the light projecting unit or the reflection unit. The coordinate input apparatus includes a moving unit configured to move a set of the light projecting unit, light receiving unit, and reflection unit in a direction perpendicular to the effective coordinate input region in order to ensure a light amount with which a pointed position in the effective coordinate input region can be calculated based on variations of a light amount distribution obtained from the light receiving unit. | 09-12-2013 |
20130257814 | COORDINATE INPUT APPARATUS - A coordinate input apparatus includes a first housing and a second housing each of which incorporate at least two sensor units each including one of the light projecting unit and one of the light receiving unit. A pointed position to an effective coordinate input region is calculated based on variations of a light amount distribution obtained from the light receiving units of each of the first and second housings. In each of the first and second housings, the field range of a light receiving unit is almost parallel to the effective coordinate input region, the optical axis direction of the light receiving unit is a direction perpendicular to a line segment connecting the barycenters of at least two sensor units in a single housing, and the field range is set to be asymmetric to the optical axis direction. | 10-03-2013 |
20140095993 | MEDICAL IMAGE DISPLAY APPARATUS,MEDICAL IMAGE DISPLAY METHOD, AND RECORDING MEDIUM - A medical image display apparatus determines a priority order of each of medical image data based on a display direction of a body model and an imaging direction of the medical image data. The medical image display apparatus displays each of the medical image data on the body model according to the priority order of the medical image data. | 04-03-2014 |
Patent application number | Description | Published |
20080286290 | Anti-Cd14 Antibody Fusion Protein - A protein comprising (I) an anti-CD14 antibody or its active fragment, or a derivative thereof and (II) an inhibitor for a protease, or its active fragment, or a derivative thereof is provided. | 11-20-2008 |
20090041783 | ANTI-PLATELET MEMBRANE GLYCOPROTEIN VI MONOCLONAL ANTIBODY - The present invention provides an antibody which has the following features, its active fragment, or a derivative thereof:
| 02-12-2009 |
20090092612 | ANTI-PLATELET MEMBRANE GLYCOPROTEIN VI MONOCLONAL ANTIBODY - The present invention provides an antibody which has the following features, its active fragment, or a derivative thereof:
| 04-09-2009 |
20110217318 | ANTI-PLATELET MEMBRANE GLYCOPROTEIN VI MONOCLONAL ANTIBODY - The present invention provides an antibody which has the following features, its active fragment, or a derivative thereof:
| 09-08-2011 |
20120277412 | ANTI-CD14 ANTIBODY FUSION PROTEIN - A protein comprising (I) an anti-CD14 antibody or its active fragment, or a derivative thereof and (II) an inhibitor for a protease, or its active fragment, or a derivative thereof is provided. | 11-01-2012 |
20130095120 | ANTI-PLATELET MEMBRANE GLYCOPROTEIN VI MONOCLONAL ANTIBODY - The present invention provides an antibody which has the following features, its active fragment, or a derivative thereof: a) It specifically binds to human platelet membrane glycoprotein VI (GPVI); b) The function to activate a platelet and/or the function to induce a thrombocytopenia in vivo are low; and c) It at least partially depletes GPVI on the platelet membrane by contacting with a platelet. | 04-18-2013 |
20140044723 | ANTI-PLATELET MEMBRANE GLYCOPROTEIN VI MONOCLONAL ANTIBODY - The present invention provides an antibody which has the following features, its active fragment, or a derivative thereof: a) It specifically binds to human platelet membrane glycoprotein VI (GPVI); b) The function to activate a platelet and/or the function to induce a thrombocytopenia in vivo are low; and c) It at least partially depletes GPVI on the platelet membrane by contacting with a platelet. | 02-13-2014 |
20140050727 | ANTI-CD14 ANTIBODY FUSION PROTEIN - A protein comprising (I) an anti-CD14 antibody or its active fragment, or a derivative thereof and (II) an inhibitor for a protease, or its active fragment, or a derivative thereof is provided. | 02-20-2014 |